Physician profile
Pen Hou
NPI 1114960937
$618.58
in general payments reported to CMS, 2019-2025
9 companies · $14.18 in 2025
The $14.18 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $150 · 2020: $15.84 · 2021: $41.60 · 2022: $28.51 · 2023: $56.39 · 2024: $312 · 2025: $14.18.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $382.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $382.19 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $155.77 | 2022-2024 | Spravato |
| Orexo US, INC. | $104.06 | 2019-2025 | Zubsolv |
| Nevro Corp. | $102.96 | 2019 | |
| Indivior INC. | $91.46 | 2019-2021 | |
| Exact Sciences Corporation | $67.75 | 2024 | Cologuard Collection Kit |
| Qiagen, LLC | $27.47 | 2024 | |
| Xeris Pharmaceuticals, INC. | $24.75 | 2024 | Gvoke Hypopen |
| Phadia US INC. | $22.26 | 2024 | Immunocap |
| Medicomp INC | $22.10 | 2023 | Telepatch Cardiac Monitor |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Pen Hou listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.